HCA Healthcare Q2 Earnings Call Highlights

HCA Healthcare Q2 Earnings Call Highlights HCA raised its 2026 outlook after second-quarter demand remained solid, with diluted EPS up 11% and admissions and ER visits still growing. However, the company said the loss of exchange coverage is sending far more patients than expected into the uninsured population, creating a bigger-than-planned hit to adjusted EBITDA. The exchange-related payer mix shift was a major pressure point, causing an estimated $400 million unfavorable EBITDA impact in Q2 and prompting full-year 2026 guidance for a $1.0 billion to $1.2 billion EBITDA headwind. HCA now expects nearly all patients losing exchange coverage to become uninsured, rather than moving to other coverage. Medicaid supplemental payment programs helped offset some of the pressure, with about $400 million of incremental net benefit in the quarter, while HCA continues to invest heavily in growth. The company has approved more than $7 billion in capital spending over the next three years, including more beds, hospitals, and outpatient facilities. HCA Healthcare NYSE: HCA said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population. Chief Executive Officer Sam Hazen said the expiration of enhanced premium tax credits at the end of 2025 led more patients to lose exchange coverage than the company had anticipated. While HCA expected some individuals to move to other coverage options, Hazen said patients instead migrated “almost one for one” to uninsured status while continuing to require hospital care. The effects, as expected, were that many people became uninsured and still needed emergency care from hospitals,” Hazen said. He added that the impact in the first half of 2026 was greater than the company’s original estimates. Payer Mix Shift Drives Updated Outlook Same-facility equivalent admissions among patients covered through health insurance exchanges declined 15% in the second quarter and year to date, according to Chief Financial Officer Mike Marks. Equivalent admissions among insured patients excluding exchange plans increased 3.2% in the second quarter, while total uninsured equivalent admissions rose 15%. Marks said the exchange-related payer mix shift created an approximately $400 million unfavorable impact on adjusted EBITDA in the second quarter. That figure included about $75 million tied to a higher estimate of the first-quarter exchange impact. The company now expects the full-year adjusted EBITDA impact from health insurance exchange changes to range from negative $1 billion to negative $1.2 billion. Marks said the updated outlook reflects the company’s conclusion that nearly all patients losing exchange coverage are becoming uninsured, compared with its prior assumption that 80% to 85% would do so. HCA also said its original expectation that uninsured patients would use fewer healthcare services did not materialize. Three divisions—Gulf Coast, North Florida and South Atlantic—accounted for about half of the companywide exchange-related impact. Hazen said exchange adjusted admissions in those divisions declined between 25% and 28% in the first half. HCA revised its full-year 2026 guidance to: Revenue of $77 billion to $79.5 billion. Adjusted EBITDA of $15.4 billion to $16.1 billion. Net income attributable to HCA Healthcare of $6.3 billion to $6.7 billion. Diluted earnings per share of $28.70 to $30.50.